Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1998-12-14
2000-11-14
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
4241331, 4241411, 5303872, C07K 1600
Patent
active
061466271
ABSTRACT:
The present invention provides an anti-idiotypic antibody having specific reactivity with an idiotope common to more than one type of anti-HIV-1 antibody, and having no specific reactivity with non-HIV-1 antibodies. The present invention provides methods of diagnosis, monitoring and treatment of HIV-related diseases through the use of this antibody or related compounds.
REFERENCES:
Askonas et al., "Dominance of a Cell Clone Forming Antibody to DNP," Nature, 238:339-341 (1972).
Briles et al., "Clonal Nature of the Immune Response," J. Exp. Med., 152:151-160 (1980).
Oellerich, "Enzyme-Immunoassay: A Review," J. Clin. Chem. Clin. Biochem., 22:895-904 (1984).
Roitt, Groves Medical Publishing Ltd., p. 103 (1985).
Nara et al., "Absence of Cytotoxic Antibody to Human Immunodeficiency Virus-Infected Cells in Humans and its Induction in Animals after Infection or Immunization with Purified Envelope Glycoprotein gp120," Proc. Natl. Acad. Sci. USA, 84:3797-3801 (1987).
Riechmann et al., Nature, 332:323-327 (1988).
Briault et al., "Isotypy of Serum Monoclonal Immunoglobulins in Human Immunodeficiency Virus-Infected Adults," Clin. Exper. Immunol., 74:182-184 (1988).
Leturcq et al., "Neutralization of HIV-1 by Anti-Idiotypic Antibodies," Fifth Int'l Conf. on AIDS, Montreal, Canada, p. 553 (1989).
Siccardi et al., "Idiotypic Reconstruction of HIV-1 GP41-GP120 Interacting Structures," Fifth Int'l Conf. on AIDS, Montreal, Canada, p. 653 (1989).
Morrow et al., "Anti-Idiotypic Antisera Raised Against Monoclonal Antibody Specific for a p24 gag Region Epitope Detects a Common Interspecies Idiotype Associated with Anti-HIV Responses," Viral Immunology, 3:99-109 (Nov., 1990).
Nara et al., "Emergence of Viruses Resistant to Neutralization by V3-Specific Antibodies in Experimental Human Immunodeficiency Virus Type 1 IIIB Infection of Chimpanzees," J. Virol. 64:3779-3791 (1990).
Muller et al., Generation and Specificity of Monoclonal Anti-Idiotypic Antibodies Against Human HIV-Specific Antibodies, J. Immunology, 147:933-941 (Aug., 1991).
Nara et al., "Neutralization of HIV-1: a Paradox of Humoral Proportions," FASEB Journal, 5:2437-2455 (1991).
Montefiori et al., "Homotypic Antibody Responses to Fresh Clinical Isolates of Human Immunodeficiency Virus," Virology, 182:635-643 (1991).
Waldmann, "Monoclonal Antibodies in Diagnosis and Therapy," Science, 252:1657-1661 (Jun. 21, 1991).
Kang et al., "Evidence for Non-v3-Specific Neutralizing Antibodies that Interfere with gp120/CD4 Binding in Human Immunodeficiency Virus 1-infected Humans," Proc. Natl. Acad. Sci. USA, 88:6171-6175 (Jul., 1991).
Matricardi et al., "Spectrotypic Analysis of Anti-gp120 Antibodies in HIV-Infected Patients," VII Int'l Conf. for AIDS, 2:167 (1991).
Halpern et al., "Human Anti-Phosphorylcholine Antibodies Share Idiotopes and are Self-Binding," J. Clin. Invest., 88:476-482 (1991).
Muller Sybille
Wang Haitao
Sidney Kimmel Cancer Center
Stucker Jeffrey
LandOfFree
Method for reducing T cell-mediated cytotoxicity in HIV using an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing T cell-mediated cytotoxicity in HIV using an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing T cell-mediated cytotoxicity in HIV using an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062301